PKPDindex: an R/CRAN package for PK/PD index analysis

Najla Alabdulkarim , Joseph F Standing

Exploration of Drug Science ›› 2026, Vol. 4 ›› Issue (1) : 1008167

PDF (1492KB)
Exploration of Drug Science ›› 2026, Vol. 4 ›› Issue (1) :1008167 DOI: 10.37349/eds.2026.1008167
Protocol
research-article
PKPDindex: an R/CRAN package for PK/PD index analysis
Author information +
History +
PDF (1492KB)

Abstract

PKPDindex() is a free and open-source R package for analysing pharmacokinetic/pharmacodynamic (PK/PD) indices, including AUC/MIC, Cmax/MIC, and T>MIC. Development was motivated by previously identified inconsistencies in PK/PD index modelling and reporting practices. The package fits eight variations of the Emax model to data and compares model performance using the Akaike information criterion (AIC) andR2 values. As input, the package requires a dataset containing PK/PD indices and a response variable. As output, it generates tables summarising all fitted models, identifies the best-fitting model for each index, and produces customisable plots of model fits with parameter estimates. PKPDindex() is freely available on CRAN (https://CRAN.R-project.org/package=PKPDindex).

Keywords

pharmacokinetic/pharmacodynamic (PK/PD) index / Emax model / R package / antimicrobial pharmacology / model fitting / dose fractionation studies / PKPDindex

Cite this article

Download citation ▾
Najla Alabdulkarim, Joseph F Standing. PKPDindex: an R/CRAN package for PK/PD index analysis. Exploration of Drug Science, 2026, 4 (1) : 1008167 DOI:10.37349/eds.2026.1008167

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti—infective drugs: an update. J Antimicrob Chemother. 2005; 55: 601-7.

[2]

Nielsen EI, Cars O, Friberg LE. Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model—Based Dose Optimization. Antimicrob Agents Chemother. 2011; 55: 4619—30.

[3]

Nielsen EI, Friberg LE. Pharmacokinetic—Pharmacodynamic Modeling of Antibacterial Drugs. Pharmacol Rev. 2013; 65: 1053-90.

[4]

Rotschafer JC, Andes DR, Rodvold KA. Antibiotic Pharmacodynamics. New York: Humana Press; 2016.

[5]

Goutelle S, Maurin M, Rougier F, Barbaut X, Bourguignon L, Ducher M, et al. The Hill equation: a review of its capabilities in pharmacological modelling. Fundam Clin Pharmacol. 2008; 22: 633-48.

[6]

Alabdulkarim N, Readman J, Mead A, Oakley R, Wenker S, Kembou J, et al. Systematic review of antimicrobial pharmacokinetic/pharmacodynamic indices in murine thigh and hollow fibre dose fractionation studies analysed with a standard method. J Antimicrob Chemother. 2025; 81: e81.

[7]

Spiess AN, Neumeyer N. An evaluation of R2 as an inadequate measure for nonlinear models in pharmacological and biochemical research: a Monte Carlo approach. BMC Pharmacol. 2010; 10: 6.

[8]

Burnham KP, Anderson DR. Multimodel Inference. Sociol Methods Res. 2004; 33: 261-304.

[9]

Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, editors. Budapest (Hungary): Akadémiai Kiadó; 1973. pp. 267-81.

[10]

Kuha J. AIC and BIC. Sociol Methods Res. 2004; 33: 188-229.

[11]

Ting N. Dose finding in drug development. Springer Science & Business Media; 2006.

[12]

Schwarz G. Estimating the Dimension of a Model. Ann Stat. 1978; 6: e6.

PDF (1492KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/